Vestrant 250 Injection 1's contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Vestrant 250 Injection 1's may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

FAQs

How does Vestrant 250 Injection 1's work?

Vestrant 250 Injection 1's contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Is Vestrant 250 Injection 1's safe for patients with liver problems?

Vestrant 250 Injection 1's is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Vestrant 250 Injection 1's.

Does Vestrant 250 Injection 1's cause weakness?

Vestrant 250 Injection 1's may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.